A jury in Florida has reportedly awarded ParkerVision Inc. (NASDAQ: PRKR) $173 million in its patent infringement suit against Qualcomm Inc. (NASDAQ: QCOM). ParkerVision had hoped for an award in the neighborhood of $430 million with a possible trebling of the award due to willfulness. The jury did not find willfulness on Qualcomm’s part which prevents the judge from awarding triple damages.
After a false alarm on Wednesday, shares were halted again on Thursday pending the jury’s verdict on the amount of damages. The jury ruled last week that Qualcomm had directly and indirectly infringed on ParkerVision patents related to capturing cell phone data at a user’s handset.
Shares were halted yesterday in anticipation of a verdict that never came and ParkerVision shares resumed trading this morning. The judge may triple whatever the jury awards, and estimates of the possible award range from a low of around $225 million to a high of $2 billion.
ParkerVision shares have about doubled including a drop of 15% Thursday. Shares posted a high of $7.78 before the share were halted on Wednesday.
The jury’s award will disappoint shareholders and today’s 15% drop will get larger once the trading halt is lifted. Shares were halted at $6.01 in a 52-week range of $1.52 to $7.78.
“The Next NVIDIA” Could Change Your Life
NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.
But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.
The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”
The report outlines key breakthroughs in AI and the stocks ready to dominate the next wave of growth. The report is absolutely free. Simply enter your email below
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.